other
confidence high
sentiment neutral
materiality 0.20
Dianthus stockholders elect directors, approve say-on-pay, ratify Deloitte at 2026 annual meeting
Dianthus Therapeutics, Inc. /DE/
- Sujay Kango, Anne McGeorge, and Jonathan Violin elected Class II directors with 42.7M, 34.8M, and 42.8M votes for, respectively.
- Advisory vote on executive compensation passed: 41.0M for, 1.7M against, 0.5M abstain, 3.6M broker non-votes.
- Ratification of Deloitte & Touche as auditor for 2026 approved: 46.3M for, 5.3K against, 0.5M abstain, no broker non-votes.
- All three proposals passed with substantial majorities; no material changes to governance disclosed.